# Apixio (Centene)

**Canonical:** https://apis.io/providers/apixio-centene/  
**Website:** https://www.apixio.com/  
**APIs profiled:** 0

Apixio is a healthcare artificial intelligence company that applies machine learning and natural language processing to unstructured clinical and claims data for value-based care, risk adjustment, HCC coding, payment integrity, and healthcare analytics. Founded in 2009 and an early Bain Capital Ventures portfolio company, Apixio was acquired by Centene Corporation in 2020; its connected-care and coding products are delivered as enterprise B2B SaaS to health plans and providers. Apixio does not currently publish a public developer portal or open API; this profile captures its identity and domain-security posture for the API Evangelist network.

## Kin Score — 5.4 / 100 (minimal)

Scored 2026-08-17 under rubric 0.11.0. Trend: flat (+0.0 from 5.4).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Commercial Clarity | 0.0 |

Regulatory layer — **Health**: 7.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Security (1)

- **Apixio Centene Domain Security** — TLSv1.3 · DNSSEC · DMARC

## Tags

Company, Healthcare, Artificial Intelligence, Machine Learning, Risk Adjustment, Value-Based Care, Payment Integrity, Health Plans

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/apixio-centene/). Scores are computed from the provider's own public artifacts under a published rubric.